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ABSTRACT 
BACKGROUND AND OBJECTIVE: Gastric cancer is the second most prevalent carcinogenic disease and 
surgery, chemotherapy and radiation are its principal treatment modalities. However, in most cases, poor response 
to treatment and adverse side effects are observed regarding these modalities. Given the lack of response to 
treatment and growing rates of gastric cancer, researchers are trying to come up with more efficient treatments 
with fewer side effects. In the traditional medicine, licorice has been suggested as a cancer treatment considering 
its high antioxidant properties and few side effects. This study aimed to evaluate the effect of licorice extract on 
gastric cancer cell lines. 
METHODS: In this experimental study, adenocarcinoma gastric cell lines were prepared from cell bank and were 
cultured. After passage, the cells were transferred into a 96-well plate. In each well, approximately 2,000 cells in 
RPMI-1640 culture medium with FBS (10%) were placed. The cells were repeatedly exposed to different 
concentrations of Glycyrrhetinic acid (0, 1, 10 and100.1 μM) and Glycyrrhizic acid (10, 1, 100 and 0.1 μM) for 24 
and 48 hours. Finally, the obtained results of the experimental and control groups were compared with each other. 
FINDINGS: According to our results, the toxic effect of Glycyrrhetinic and Glycyrrhizic acids is dose and time 
dependent. In 24 hours, the mean optical density (MOD) in 100 μM concentration of Glycyrrhetinic acid was 
0.41±0.02 and 0.79±0.04 in the experimental and control groups, respectively (p=0.0002). After 48 hours, MOD 
was 0.16±0.004 and 1.749±0.24 in the experimental and control groups, respectively (p=0.0003). Moreover, the 
MOD of 100 μM concentration of Glycyrrhizic acid was 0.78±0.53 and 2.09±0.49 in the experimental and control 
groups in 48 hours. There was a significant difference between the experimental and control groups (p=0.035). 
CONCLUSION: The results of this study demonstrated that the licorice compounds have a toxic effect on 
carcinogenic cells. Therefore, it is recommended to perform more study on both Glycyrrhizic and Glycyrrhizic 
acids as effective compounds on gastric cancer treatment. 
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Introduction 
Gastric cancer is the second most prevalent 
carcinogenic disease. Epidemiological studies have  
 
demonstrated that gastric cancer is the second 
leading cause of death (due to cancer) in the world 
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following lung cancer (1). In 2014, the number of 
patients with gastric cancer in the USA was 
reported to be 1665540, out of which 585720 cases 
died (2). Gastric cancer is often asymptomatic in 
the early stages and the lack of clinical symptoms 
in these patients leads to delayed diagnosis. Almost 
80-90% of these patients refer to hospitals in the 
advanced stages of the disease with adjacent 
metastasis. According to epidemiological studies, 
chance of survival in the patients with advanced 
stages of gastric cancer with metastasis is very low 
despite undergoing chemotherapy and aggressive 
treatments such as surgery for five years (3). 
Current studies have focused much attention on the 
use of natural products for the treatment of different 
diseases and have reached significant results in this 
regard. Many studies showed that the use of natural 
products could be useful in numerous areas such as 
strengthening the immune system (4, 5), treating 
incurable diseases such as Alzheimer's (6, 7), 
atherosclerosis (8,9), diabetes (10, 11), 
gastrointestinal diseases (12, 13) and cancer (14, 
15). In fact, it has created high hopes for prevention 
and treatment of several diseases. Licorice is one of 
effective plants in the treatment of numerous 
diseases. Flavonoids derived from licorice root are 
also applied for treatment of many diseases 
including microbial infections causing hepatitis C, 
stomach ulcer, skin and respiratory infections; it is 
also used as a carcinogenic treatment (16). Licorice 
is from the Fabaceae family (also known as 
Glycyrrhiza glabra). In European and Asian 
traditional medicine, it was used for treatment of 
gastritis, peptic ulcers and respiratory infections 
(16). This plant is grown in many countries and is 
known as an anti-inflammatory, antitumor and 
antioxidant substance. Anti-tumor activities of the 
licorice compounds include cell cycle arrest, 
apoptosis inducing and antioxidant effects. 
According to the studies conducted on the lab rats, 
some licorice compounds inhibit PI3-K, MKK4, 
MKK7, JNK1, mTOR, and Cdk2 activities through 
reducing carcinogenesis in several cells (4). 
Additionally, licorice is used for the treatment of 
viral hepatitis and cytomegalovirus (CMV) 
infection. Moreover, Glycyrrhizic acid derived 
from licorice prevents the growth of viruses and 
viral components (5, 6). Glycyrrhetinic acid and 
Glycyrrhizic acid are two compounds isolated from 
licorice. Glycyrrhetinic acid is a pentacyclic 
triterpenoid derivative of the Glycyrrhizic acid 
(formula: C₃₀H₄₆O₄) which is obtained from 
licorice. Glycyrrhizic acid is a natural substance 
comprising of Glycyrrhetinic acid and two 
molecules of Glucuronic acid (7). Glycyrrhizic acid 
and Glycyrrhetinic acid can effect on the androgen 
steroids’ activity through acting on glucocorticoid 
receptors and preventing the conversion of cortisol 
to cortisone in liver and kidney. In addition, 
compounds in licorice extract can cause 
lipoxygenase and cyclooxygenase disruption as 
well as arachidonic acid reduction. Glycyrrhetinic 
acid is used as an analgesic and anti-inflammatory. 
It is also used for treatment of allergy, gastric ulcer, 
hepatitis, liver toxicity and tumors. Glycyrrhetinic 
acid is an active pharmaceutical ingredient. It helps 
with reducing lipids through elevating the level of 
corticosterone (8, 9). In rats, Glycyrrhetinic acid 
plays a key role in prevention of development and 
progression of tumors by means of DMBA (7, 12-
DiMethyl Benz (a) Anthracene) (trans-7, 12-
dimethyl benzene) and TPA (12-o-
Tetradecanoylphorbol-13-Acetate) (10), while 
Glycyrrhizic acid prevents the formation of tumors 
only by means of DMBA and TPA has no role (11). 
Given the efficacy of licorice compounds in 
treatment of various diseases with few side effects, 
this study aimed to determine the effects of 
Glycyrrhetinic acid and Glycyrrhizic acid derived 
licorice extract on gastric carcinogenic cell line.  
 
 
Methods  
Cell Culture: In our study, the components of 
Glycyrrhetinic acid and Glycyrrhizic acid were 
purchased from the Sigma Company and AGS 
carcinogenic cell line (adenocarcinoma gastric cell 
line) was purchased from Pasteur Institute (Tehran, 
Iran). The cells were cultured in 25 ml flasks 
containing 5 ml culture medium (the culture 
conditions: RPMI-1640 containing FBS (10%) 
(Gibco, Manchester, UK). These cells were 
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incubated at 37 °C containing 5% CO2. The culture 
medium was changed every 24 hours. Three or four 
days following the primary culture, cell density was 
evaluated under an inverted microscope. When the 
cells were grown to 80%, the passage was 
performed.  
Cell viability:Approximately 2,000 cells in 50 μL 
RPMI-1640 culture medium containing 10% Fetal 
Bovine Serum (FBS) were added to each well in a 
96-well plate and were kept in the CO2 
incubator overnight. Subsequently, the cells were 
repeatedly exposed to different concentrations of 
Glycyrrhetinic acid (0.1, 1, 10 and100 μM) and 
Glycyrrhizic acid (0.1, 1, 10 and100 μM), which 
were dissolved in dimethyl sulfoxide. A control 
group was considered for each concentration of 
Glycyrrhetinic and Glycyrrhizic acids. The control 
group was only located in a RPMI-1640 culture 
medium with FBS (10%). The cells were incubated 
with different amounts of the Glycyrrhetinic acid 
and Glycyrrhizic acid for 24 and 48 hours. After the 
incubation time, 10 ml of XTT solution (salt, 2, 3-
bis, (2-methoxy-4-nitrobenzonitrile-5 
sulfosuccinates) 2 tetrazolium-5 carboxyaniline) 
was added to each well in a 96-well plate in order 
to evaluate cell viability. After a 4-hour period, 
supernatant reading was evaluated by dint of 
ELISA (Stat Fax, Palm City, FL) and mean optical 
density (MOD) at 540 nm in each well was 
performed (12). The optical density of cells 
determined by ELISA was converted into 
percentage of cell viability using the following 
formula:  
Percentage viability= 
average OD of cell control 
×100 
test OD 
All the tests were repeated three times. The 
cells were repeatedly exposed to various 
concentrations of Glycyrrhetinic acid and 
Glycyrrhizic acid for 24 and 48 hours, then, MOD 
was calculated. Eventually, statistical analysis was 
performed.  
Statistical analysis: In this study, SPSS was used 
to analyze the data and independent Kruskal-Wallis 
and Dunn's post hoc test were performed. p<0.05 
was considered significant in all the analysis. 
 
Result 
The incubation of AGS cells with different 
concentrations of Glycyrrhetinic acid: The obtained 
results showed that the lowest percentage of cell 
survival was observed in 100 μM concentrations 
among different concentrations (0.1, 1, 10 and100 
μM) of Glycyrrhetinic acid after 24 hours of 
incubation. The MOD in 100 μM concentrations of 
Glycyrrhetinic acid was 0.41±0.02 and 0.79±0.04 in 
the experimental and control groups, respectively. 
There was a significant difference between the two 
groups (p=0.0002, CI95%) (fig 1. A). In addition, 
48-hours incubation of AGS cells demonstrated the 
lowest percentage of cell survival in 100 μM 
concentrations of Glycyrrhetinic acid. The MOD in 
100 μM concentrations was 0.16±0.004 and 
1.749±0.24 in the experimental and control groups, 
respectively. The comparison between the two 
groups showed that there was a significant 
difference between the experimental and control 
groups (p=0.0003, CI95%) (fig 1. B).  
The incubation of AGS cells with different 
concentrations of Glycyrrhizic acid: After 24 
hours of incubation, the lowest percentage of cell 
survival was observed in 100 μM  concentrations of 
Glycyrrhizic acid. The MOD in 100 μM 
concentrations was 0.33±0.29 and 0.81±0.08 in the 
experimental and control groups, respectively.  The 
comparison between the experimental and control 
groups demonstrated that there were no significant 
differences between the two groups (fig 2. A). 
What’s more, in 48-hours incubation of AGS cells, 
the lowest percentage of cell survival was observed 
in 100 μM concentrations of Glycyrrhizic acid. The 
MOD in 100 μM concentrations of Glycyrrhizic 
acid was 0.78±0.53 and 2.09±0.49 in the 
experimental and control groups, respectively. 
There was a significant difference between the two 
groups (p=0.035, CI95%) (fig 2. B). In our study, 
AGS cells were treated for 24 and 48 hours with 
various concentrations of glycyrrhetinic acid and 
glycyrrhizic acid. The increased cell death was 
observed at high doses of Glycyrrhetinic acid  and 
Glycyrrhizic acid. Therefore, the effectiveness of 
these herbs is dose dependent, i.e., the rate of cell 
death increases by increasing the dose of these 
herbal medicines (fig 3).  
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Figure 1. The percentage of cell survival in AGS cells after 24 (a) and 48 (b) hours of exposure to different 
concentrations of Glycyrrhetinic acid 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2. The percentage of cell survival in AGS cells after 24 (a) and 48 (b) hours of exposure to different 
concentrations of Glycyrrhizic acid 
 
 
  
  
 
 
 
 
 
 
 
 
 
Figure 3. The number of AGS cells decrease by increasing the dose of Glycyrrhetinic acid and Glycyrrhizic 
acid(a-d). (The greatest amount of cell death in 100 μM concentration(d)) 
  
Discussion 
According the obtained results, two compounds 
derived from licorice (Glycyrrhetinic acid and 
Glycyrrhizic acid) increased the rate of 
carcinogenic cells death following 24 and 48 hours 
of incubation. A study performed to determine the 
effect of Glycyrrhetinic acid on NCI-H460 NSCLC  
 
 
cells showed that inducing apoptosis and cell cycle 
arrest occurred in G1 phase. This might be due to 
an increase in the PARP (Poly ADP-ribose 
polymerase) and caspase-3 expression and a 
decrease in Bcl-xl, BCL2, cyclin D1 and cyclin E 
expression. Moreover, Glycyrrhetinic acid leads to 
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decreased amount of protein kinase C-beta (PKC-
beta) phosphorylates and extracellular signal-
regulated kinase (ERK) phosphorylates and 
increased phosphorylation of protein kinase Cδ 
(PKCδ) and c-Jun N-terminal kinases (JNKs), both 
of which can affect cell death (13). The 
aforementioned processes are the possible 
mechanisms involved in gastric cancer treatment. In 
an investigation of the anti-carcinogenic effects of 
licorice extract components on gastric cancer cells 
and immortalized gastric epithelial cell lines, it was 
found that Licochalcone A, which is isolated from 
root of Glycyrrhiza glabra (licorice), is the most 
toxic component of the licorice that has the greatest 
impact on cell cycle arrest and inducing apoptosis. 
Some researchers have indicated that licorice 
extract Licochalcone A prevents the growth of 
carcinogenic cells in a dose-dependent manner. 
Moreover, they reported that the Licochalcone A 
component of licorice extract  induced lowered 
expression of cyclin A, cyclin B and murine double 
minute 2 homolog (MDM2) oncogene. 
Additionally, it leads to increased expression of 
retinoblastoma protein (Rb) in the carcinogenic 
cells. Furthermore, Licochalcone A component of 
licorice extract causes apoptosis through affecting 
on the expression of Bcl-2, BaX and caspase 3. 
These findings suggest that licorice extract is 
effective in treatment of gastric cancer (14). 
Another study pointed out that the licorice extract 
induces elevated expression of BaX and decreased 
expression of Bcl2, MKN-28 (significantly), AGS 
(moderately), and MKN-45 cells (slightly). 
Therefore, the increase in the ratio of Bax/Bcl-2 
leads to release of cytochrome C from mitochondria 
to the cytosol where cytochrome C can bind to 
apoptotic protease, activating factor1 that is also 
known as APAF-1. This causes inducing apoptosis 
in cells and caspase-3 and poly (ADP-ribose) 
polymerase (PARP) activation (15). The obtained 
results of our study showed two compounds derived 
from licorice (Glycyrrhetinic acid and Glycyrrhizic 
acid) had a toxic effect on carcinogenic cells. 
According to our study, Glycyrrhetinic acid is more 
effect than Glycyrrhizic acid in treatment of gastric 
cancer. Therefore, Glycyrrhetinic acid as an 
effective combination treatment can be employed 
for treatment of gastric cancer.  Although the 
combination of Glycyrrhizic acid prevents the 
growth of carcinogenic cells, its influence is more 
gradual than Glycyrrhetinic acid. These differences 
might lead to various neurological pathways to 
prevent the growth of carcinogenic cells and could 
induce different effects on the AGS cell line. 
Impacts of oxidative stress on numerous diseases 
such as cancer (16,17) and also the effects of 
antioxidants on various diseases, especially the 
diseases associated with free radicals and oxidative 
stress such as cancer (19, 20), diabetes (21-23), 
infection (24,25) and atherosclerosis (26) (27) have 
been determined. In other words, the antioxidant 
effects of Glycyrrhetinic acid and Glycyrrhizic acid 
might result in carcinogenic cells’ death. There are 
numerous plants with antioxidant properties (25, 
28-31), the anti-carcinogenic effects of which must 
be examined.  
According to our study, Glycyrrhetinic acid 
had a more significant impact on treatment of 
gastric cancer in a shorter time as compared to 
Glycyrrhizic acid. Thus, it can be applied for 
gastric cancer treatment. Further in-vivo studies are 
required to determine the positive effects of these 
components on gastric cancer treatment 
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